ArticleCancer research communications2025

Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma.

Michelle Greenman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.